Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,131.83
(
-0.59%
)
US TECH 100
26,263.80
(
-1.15%
)
Dow Jones
49,196.58
(
-0.23%
)
Brent Oil
104.27
(
2.11%
)
Bitcoin
76,185.91
(
-1.53%
)
News Focus
News Focus
Post# of 517629
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Steady_T

Send PM Follow Ignore
Followers 170
Posts 23071
Boards Moderated 1
Alias Born 12/09/2004

Steady_T

Member Level

Re: scorman1 post# 437793

Thursday, 11/02/2023 12:11:07 AM

Thursday, November 02, 2023 12:11:07 AM

Post# of 517629
I am reminded of a comment by Carl Sagan " Extraordinary claims require extraordinary evidence".
Anavex is challenging the entire Alzheimer's disease paradigm.

So yes, the FDA will be looking much more carefully at Anavex's data and trials before granting approval.

The real folly is ignoring the progress the company has made.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News